Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - PRE-TAX INCOME
Pre-tax Income SMMT - Summit Therapeutics Inc.
-616 M
LAST VALUE
-163.65%
2 YEAR CAGR
-148.28%
5 YEAR CAGR
-49.49%
10 YEAR CAGR